5. ROBINS‐I assessment by study: Soluyanov 2018.
Study name:Soluyanov 2018 | |||
Risk of bias domain | Assessments by outcome | Support for judgment | Conclusion |
Bias due to confounding | Urologic symptom scoresa | Quote: "patients were assigned to one of three groups (i.e., planning one of three operations) taking into account the volume of the prostate gland and the presence of concomitant chronic diseases". Judgment: participants were selected based on participant characteristics and post intervention and study author did not use an appropriate analysis method that controlled for confounding. |
Critical |
Bias in selection of participants into the study | Quote: "patients were assigned to one of three groups (i.e., planning one of three operations) taking into account the volume of the prostate gland and the presence of concomitant chronic diseases". Judgment: participants were selected based on prostate volume related to the results of outcomes. |
Critical | |
Bias in classification of interventions | Judgment: likely prospective comparative trial with predefined criteria for the intervention. | Moderate | |
Bias due to deviations from intended interventions | Judgment: no information with regard to co‐intervention and analysis used to estimate the effects of starting and adhering to the intervention. | No information | |
Bias due to missing data | Judgment: all participants were included in the analysis. | Low | |
Bias in measurement of outcomes | Judgment: given that study outcomes were subjective, outcome measures were likely influenced by knowledge of the intervention received. | Serious | |
Bias in selection of the reported result | Judgment: study outcomes were not well predefined and described, and the protocol was not found. | No information | |
Overallb | — | Judgment: critical risk of bias in ≥ 1 domain. | Critical |
ROBINS‐I: risk of bias tool to assess non‐randomized studies of interventions. aThe review outcome reported in study.